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Abstract. 
 
Aspects of protein disulfide isomerase (PDI) 
function have been studied in yeast in vivo. PDI con-
 
tains two thioredoxin-like domains, 
 
a
 
 and 
 
a
 
9
 
, each of 
which contains an active-site CXXC motif. The relative 
importance of the two domains was analyzed by ren-
dering each one inactive by mutation to SGAS. Such 
mutations had no significant effect on growth. The do-
mains however, were not equivalent since the rate of 
folding of carboxypeptidase Y (CPY) in vivo was re-
duced by inactivation of the 
 
a
 
 domain but not the 
 
a
 
9
 
 do-
main. To investigate the relevance of PDI redox poten-
tial, the G and H positions of each CGHC active site 
were randomly mutagenized. The resulting mutant 
PDIs were ranked by their growth phenotype on me-
dium containing increasing concentrations of DTT. The 
rate of CPY folding in the mutants showed the same 
ranking as the DTT sensitivity, suggesting that the oxi-
dative power of PDI is an important factor in folding in 
vivo. Mutants with a PDI that cannot perform oxida-
tion reactions on its own (CGHS) had a strongly re-
duced growth rate. The growth rates, however, did not 
correlate with CPY folding, suggesting that the pro-
tein(s) required for optimal growth are dependent on 
PDI for oxidation. 
 
pdi1
 
-deleted strains overexpressing 
the yeast PDI homologue 
 
EUG1
 
 are viable. Exchang-
ing the wild-type Eug1p C(L/I)HS active site sequences 
for C(L/I)HC increased the growth rate significantly, 
however, further highlighting the importance of the ox-
idizing function for optimal growth.
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F
 
ormation 
 
of correct disulfide bonds is essential for
proper folding of the majority of secretory proteins
in eukaryotic cells. Refolding of proteins contain-
ing more than one disulfide bond in vitro is stimulated by
the enzyme protein disulfide isomerase (PDI)
 
1
 
 (Givol et
al., 1965). PDI of mammalian origin has a characteristic
 
a
 
-
 
b
 
-
 
b
 
9
 
-
 
a
 
9
 
-
 
c
 
 domain structure (Edman et al., 1985). The 
 
a
 
and 
 
a
 
9
 
 domains have sequence and structural homology to
 
thioredoxin (Kemmink et al., 1996; Fig. 1 
 
A
 
). The 
 
b
 
 and 
 
b
 
9
 
domains are characterized by mutual homology. The
COOH-terminal 
 
c
 
 region is rich in acidic residues, and is
thought to be involved in binding of calcium ions (Leb-
eche et al., 1994; Nigel Darby, EMBL, Heidelberg, per-
sonal communication).
Members of the thioredoxin family contain two catalyti-
cally active cysteine residues found in a CXXC motif. The
identity of the two X residues varies among the family
members, but catalysis is always mediated by reduction
and oxidation of an internal disulfide bond between the
cysteine residues of the active site (Martin, 1995). As the
name would indicate, isomerization of disulfide bonds is
an important feature of PDI. What is less widely acknowl-
edged is that PDI may also play an important role in the
oxidation of newly synthesized proteins. Detailed bio-
chemical analysis has shown that the 
 
a
 
 and 
 
a
 
9
 
 domains of
PDI are capable of catalyzing two kinds of disulfide reac-
tions (Creighton et al., 1980; Darby and Creighton, 1995
 
a
 
):
(
 
a
 
) oxidation reactions in which the intramolecular disul-
fide bond of the CGHC motif is transferred to a pair of
sulfhydryls in a substrate polypeptide (Fig. 1 
 
B
 
); and (
 
b
 
)
isomerization reactions in which disulfides are rearranged
through the formation of a mixed disulfide between the
first cysteine residue of the CGHC motif and the substrate
(Fig. 1 
 
C
 
).
In the eukaryotic cell, PDI is localized to the ER. Glu-
tathione and glutathione disulfide (GSSG) are believed to
function as the redox buffer since they are found at ap-
proximately equal millimolar concentrations in the ER,
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providing a much more oxidizing environment than the cy-
toplasm (Hwang et al., 1992).
In yeast, the structural gene for PDI, 
 
PDI1
 
, is essential
for viability (Farquhar et al., 1991; LaMantia et al., 1991;
Günther et al., 1991; Scherens et al., 1991). When PDI is
 
depleted from the cells, a secretory pathway marker pro-
tein accumulates in the ER, suggesting an impairment in
folding (Günther et al., 1991; Tachibana and Stevens,
1992). Despite the potentially central role that PDI plays
in the folding of newly synthesized secretory pathway pro-
teins, little has been done to dissect the functional aspects
of its role in folding in vivo. In the present work, we have
analyzed the effects of various mutations in 
 
PDI1
 
 on the
folding of a yeast vacuolar protein, carboxypeptidase Y
(CPY). CPY has a number of virtues that make it a very
useful model for the study of in vivo folding and secretory
transport. Changes in molecular mass that accompany its
transport through different compartments of the secretory
pathway can be followed in pulse-labeling experiments
(Stevens et al., 1982). Upon translocation into the ER, the
polypeptide receives four core 
 
N
 
-glycosyl residues, result-
ing in the p1 form of proCPY, which has a molecular mass
of 67 kD. The core glycosyl structures are further modified
in the Golgi compartment to give the 69-kD p2 form of
proCPY. This form is sorted to the vacuole, where it is
processed to its mature form of 63 kD. The individual
transport steps are easily followed in 
 
35
 
S pulse-labeling ex-
periments, and the total sequence of events has a half time
of 
 
z
 
6 min. As in mammalian systems, proteins that do not
fold into their correct three-dimensional structure are re-
tained in the ER. Thus, ER retention is an indication of
misfolding. In a more direct assay, the in vivo folding rate
was monitored using a mutant form of CPY (CPY-3T)
that contains a new glycosyl acceptor site that is inaccessi-
ble in the folded protein. Treatment of whole cells with
DTT may block the folding of many disulfide bond–con-
taining proteins by preventing oxidation of the cysteine
residues of the newly synthesized proteins (Braakman et
al., 1991). In yeast cells, DTT treatment results in accumu-
lation of p1-proCPY (Simons et al., 1995) and, in the case
of proCPY-3T, modification of the new glycosylation site
(Holst et al., 1996). In strains expressing some mutant alleles
of 
 
PDI1
 
, we found this modification was present on CPY-3T
at a level approaching that of DTT-treated cells. These ob-
servations are consistent with the view that not only is for-
mation of the five disulfide bonds of the protein essential
for correct folding, but also that mutations in PDI can af-
fect the rate of folding in vivo even when no growth phe-
notype is obvious.
 
Materials and Methods
 
Strains
 
Saccharomyces cerevisiae
 
 strains W303-1B
 
aD
 
pdi1 (
 
MAT
 
a
 
 
 
ade2-1 can1-
100 ura3-1 leu2-3,112 trp1-1 his3-11,15 
 
D
 
pdi1::HIS3
 
) and M4143 (
 
MAT
 
a
 
ade2-1 can1-100 ura3-1 leu2-3,112 trp1-1 his3-11,15 
 
D
 
pdi1::HIS3 
 
D
 
prc1-17
 
)
containing either pCT37, pCT40 (Kurjan, 1985; Tachibana and Stevens,
1992), or pBH1464 was used for plasmid shuffling and characterization of
the different 
 
pdi1
 
 mutants. M4143 was constructed by gene replacement
(Scherer and Davis, 1979) of 
 
PRC1
 
 using plasmid pWI-17 (Holst et al.,
1996).
 
Escherichia coli strains. 
 
DH5
 
a
 
 (Sambrook et al., 1989) was used for
plasmid propagation, BMH71-18
 
mutS
 
 (Kramer et al., 1984; Zell and Fritz,
1987), CJ236 (Kunkel et al., 1987), and JM109 (Yanisch-Perron et al.,
1985) were used for site-directed mutagenesis. Yeast strain JWY33-2B
(
 
MAT
 
a
 
 
 
ura3-52 leu2-3,112 trp1-1 sec18-1 
 
D
 
pdi1::HIS3 
 
D
 
prc1-17
 
) was con-
structed by crossing M4143 with XCR101-12 (
 
MAT
 
a
 
 
 
ura3-52 sec18-1 his3
leu2-3,112
 
) using standard genetic procedures (Sherman, 1991).
Figure 1. (A) Sequences of PDI and Eug1p from yeast and
thioredoxin from E. coli surrounding the active site CXXC motifs
(boxed). A section of the a and a9 domains of PDI and Eug1p is
compared, and the location of the predicted secondary structure
features is indicated by b2 (second b-sheet structure) and a2 (sec-
ond a-helix structure). Residues that are found in a majority of
the sequences are underlined. (B) Reaction cycle for oxidation of
nascent polypeptide (ProteinSH/SH) catalyzed by PDI. The puta-
tive involvement of GSSG in the oxidation cycle is indicated. The
upper SH group of PDI (PDISH) indicates the NH2-proximal cys-
teine residue of the CXXC motif. This is the more reactive resi-
due and will engage in the formation of mixed disulfides with the
substrate, here shown only for the protein substrate although a
similar reaction pathway exists for GSSG reduction. PDISH indi-
cates the more COOH-proximal cysteine residue, which is in-
volved in the formation of the internally oxidized form of PDI. In
mutant forms of PDI lacking the COOH-proximal cysteine, oxi-
dation of substrate protein can occur, albeit inefficiently, by re-
duction of a mixed disulfide between glutathione and the PDI
NH2-proximal cysteine residue. (C) Isomerization reaction in
which the NH2-proximal cysteine residue of the CXXC motif at-
tacks a wrongly formed disulfide of a substrate protein. The for-
mation of mixed intermediate I allows a free SH group of the
substrate to form an alternative SS bond. Importantly, the more
COOH-proximal cysteine residue does not participate in this re-
action cycle. 
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Media and Materials
 
Yeast cells were grown in standard YPD and SC media (Sherman, 1991).
 
E. coli
 
 was grown in LB, SOC, and 2
 
3
 
 YT medium (Sambrook et al.,
1989). Restriction enzymes, T4 DNA polymerase, T4 polynucleotide ki-
nase, T4 DNA ligase, and Klenow polymerase were from Promega (Madi-
son, WI). [
 
35
 
S]methionine was from DuPont NEN (Boston, MA). Zymo-
lase 100-T was from Seikagaku Kogyo (Tokyo, Japan). Fixed 
 
Staphylococcus
aureus
 
 cells were IgGsorb from The Enzyme Center (Malden, MA). Oli-
gonucleotides were from DNA Technology (Aarhus, Denmark). Se-
quencing was performed using a 
 
Taq
 
 Dye Deoxy™ terminator cycle se-
quencing kit on an API 373A DNA Sequencer, both from Applied
Biosystems (Foster City, CA).
 
Plasmid Construction and Mutagenesis
 
Subcloning and transformation of 
 
E. coli
 
 and yeast were carried out using
standard procedures (Sambrook et al., 1989; Ito et al., 1983). The plasmids
used in this study, the resulting 
 
PDI1
 
 alleles, and the encoded enzymes are
listed in Table I. pBH1464 was constructed by subcloning of a KpnI-SacI
fragment from pCT38 (Tachibana and Stevens, 1992) into the same sites
in pRS314 (Sikorski and Hieter, 1989). pBH1514 was constructed by sub-
cloning a KpnI-XbaI fragment from pCT38 into the same sites in pSE-
LECT (Lewis and Thompson, 1990). Site-directed mutagenesis was per-
formed as described previously (Lewis and Thompson, 1990) with the
modification described by Olesen and Kielland-Brandt (1993). For clon-
ing purposes, a BamHI site was introduced by site-directed mutagenesis
into the 
 
PDI1
 
 promoter region, generating pBH1857 after reconstitution
in an otherwise wild-type context. Pulse-labeling and growth experiments
showed no change in phenotype, as compared to the wild-type 
 
PDI1
 
 (data
not shown). pBH1852, pBH1630, and pBH1692, containing serine resi-
dues instead of cysteine residues at the 
 
a
 
 site, the 
 
a
 
9
 
 site, and both the 
 
a
 
and the 
 
a
 
9
 
 active sites, respectively, were generated by site-directed mu-
tagenesis (Table I). pBH1680 was constructed by recloning of a KpnI-
XbaI fragment from pBH1692 into pSELECT in the same sites. pBH1680
was used for site-directed mutagenesis to randomize the two middle
amino acids in either of the two active sites (CGHC). Table I lists the mu-
tants reconstituted into an otherwise wild-type 
 
PDI1
 
 context, except for
the already introduced alterations. Likewise, mutants with serine residues
instead of cysteine residues in the most COOH-proximal cysteine in either
of the two active sites or in both active sites, were generated by site-
directed mutagenesis in pBH1680 followed by a similar reconstitution
(Table I). 
 
EUG1
 
 was mutated using conventional techniques (Kunkel et
al., 1987; Herlitze and Koenen, 1990) and subcloned into pBH1865 to
place the gene under 
 
PDI1
 
 promoter control.
 
Characterization of pdi1 Mutants
 
Pulse labeling and immunoprecipitation were performed essentially as de-
scribed by Winther et al. (1991). Yeast cells were grown in SC-trp-ura and
starved for sulfur in SC-trp-ura without (NH
 
4
 
)
 
2
 
SO
 
4
 
. [
 
35
 
S]methionine was
used for labeling instead of [
 
35
 
S]H
 
2
 
SO
 
4
 
. When indicated, DTT was added
to give final concentrations of 5 mM. For pulse labeling, 
 
PRC1
 
 alleles en-
coding wild-type CPY or CPY with an extra 
 
N
 
-glycosylation site (CPY-
3T; Holst et al., 1996) were reintroduced via plasmids pJW1433 (Ramos et
al., 1994) and pBH994, respectively. The randomly mutagenized 
 
pdi1
 
 mu-
tants were screened for their ability to grow in the presence of different
concentrations of DTT. The final concentration of DTT varied between 0
and 5 mM. Overnight cultures grown in the absence of DTT were diluted
10
 
4
 
 times in water, aliquots of 10 
 
m
 
l were placed on freshly made SC plates
buffered to pH 5 with 50 mM NaH
 
2
 
PO
 
4
 
, and the plates were subsequently
incubated in a CO
 
2
 
 atmosphere to prevent oxidation of the DTT by O
 
2
 
.
After 48 and 72 h at 30
 
8
 
C, the mutants were ranked according to the max-
imal DTT concentration at which they were able to grow. Several inde-
pendent experiments showed variation in ranking of no more than two po-
sitions.
 
Results
 
Analysis of the Relative Importance of 
 
a
 
 and
 
a
 
9
 
 Domains
 
To evaluate the relative importance of the two thiore-
doxin-like domains of PDI, mutant forms of the protein
were constructed containing either of the two CGHC ac-
tive site motifs converted to SGHS. Such mutations impair
the ability of the mutated active site to engage in disulfide
chemistry. Since 
 
PDI1
 
 is an essential gene, we used a plas-
mid-shuffle procedure (Sikorski and Boeke, 1991) to in-
troduce the mutant genes. Mutants were introduced on a
plasmid containing a TRP1 selectable marker into a Dpdi1
strain that carried PDI1 on a plasmid with a URA3
marker. After transformation, the cells were forced to lose
the plasmid-containing wild-type PDI1 by plating on me-
dium containing 5-fluoro orotic acid, which selects cells
that have lost URA3. Cells will be able to grow only if the
newly introduced PDI mutant form can complement the
chromosomal pdi1 deletion. Consistent with the theory
that the essential activity of PDI is dependent on its ability
to engage in disulfide chemistry, we found that a SGHS-
SGHS2 mutant is not able to complement Dpdi1.
Cells producing the CGHC-SGHS or SGHS-CGHC
mutant enzymes as their sole PDI forms showed no
growth defect under normal conditions. To investigate
protein folding in vivo in these strains, we monitored the
2. We have adopted a nomenclature for mutants in PDI in which the
amino acid sequence of a and a9 active sites, respectively, are written out
in single-letter abbreviation.
Table I. Plasmids Used
Name PDI1 allele Enzyme
pCT37 GAL-PDI1 CGHC-CGHC
pCT38 PDI1 CGHC-CGHC
pBH1464 PDI1 CGHC-CGHC
pBH1514 PDI1-1514 CGHC-CGHC
pBH1630 pdi1-1630 CGHC-SGHS
pBH1680 pdi1-1680 SGHS-SGHS
pBH1692 pdi1-1692 SGHS-SGHS
pBH1703 pdi1-1703 CGSC-SGHS
pBH1704 pdi1-1704 CWSC-SGHS
pBH1706 pdi1-1706 CRPC-SGHS
pBH1708 pdi1-1708 CGGC-SGHS
pBH1711 pdi1-1711 CRRC-SGHS
pBH1715 pdi1-1715 SGHS-CCPC
pBH1722 pdi1-1722 SGHS-CSGC
pBH1731 pdi1-1731 CSGC-SGHS
pBH1732 pdi1-1732 CLYC-SGHS
pBH1733 pdi1-1733 SGHS-CPKC
pBH1734 pdi1-1734 SGHS-CKAC
pBH1735 pdi1-1735 SGHS-CNCC
pBH1736 pdi1-1736 SGHS-CRSC
pBH1737 pdi1-1737 CGCC-SGHS
pBH1738 pdi1-1738 CWLC-SGHS
pBH1739 pdi1-1739 CKIC-SGHS
pBH1741 pdi1-1741 SGHS-CGTC
pBH1742 pdi1-1742 SGHS-CRNC
pBH1743 pdi1-1743 SGHS-CGEC
pBH1744 pdi1-1744 SGHS-CPSC
pBH1745 pdi1-1745 SGHS-CVDC
pBH1746 pdi1-1746 SGHS-CHQC
pBH1852 pdi1-1852 SGHS-CGHC
pBH1857 PDI1-1857 CGHC-CGHC
pBH1945 pdi1-1945 CGHS-SGHS
pBH1960 pdi1-1960 SGHS-CGHS
pBH1966 pdi1-1966 CGHS-CGHS
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rate of intracellular transport of CPY. Cells were pulse-
labeled with 35S for 15 min, and were chased with nonra-
dioactive sulfur for 0, 5, and 15 min before lysis and immu-
noprecipitation of CPY antigen. The precipitates were
subjected to SDS-PAGE, and the gels were exposed to
x-ray film or PhosphorImager screens. As described in the
introduction, CPY undergoes a number of modifications
in the secretory pathway that allow estimation of the rate
of transport between the ER, Golgi, and vacuole. Fig. 2 A
shows that while the rate of CPY maturation is essentially
the same in wild-type and CGHC-SGHS mutants, the half
time of CPY maturation is 15–20 min in the SGHS-CGHC
mutant. Since only folded proteins are allowed to exit the
ER, (Gething et al., 1986) this shows that the a domain
plays a more important part in folding of CPY than the a9
domain.
Treatment of intact yeast or mammalian cells with DTT
results in ER accumulation of newly synthesized, disul-
fide-containing secretory proteins in a reduced state
(Braakman et al., 1991; Jämsä et al., 1994). To test the
ability of the PDI mutants to oxidize proCPY after DTT
treatment, we carried out the following experiment. Cells
were treated with 5 mM DTT during labeling with 35S, af-
ter which they were washed and chased with nonlabeled,
DTT-free medium. As seen in Fig. 2 B (lanes 1, 4, and 7),
all strains accumulate p1-proCPY in the ER during a DTT
pulse. We find that the rate of maturation is comparable in
the wild-type cells and in those expressing the CGHC-
SGHS form of PDI. In cells producing the SGHS-CGHC
mutant, no mature CPY is found, even 60 min after DTT
washout. The simplest explanation for this effect on CPY
folding is that reoxidation of ER components is slower in
this mutant than in the CGHC-SGHS mutant or the wild
type.
Random Mutagenesis of the CGHC Sequence of the 
Thioredoxin Domains
The redox potential of thioredoxin and DsbA (an E. coli
analogue of PDI; Bardwell et al., 1991) is strongly depen-
dent on the identity of the two central amino acid residues
of the CGHC motif (Grauschopf et al., 1995; Chivers et al.,
1996). To investigate the importance of the redox poten-
tial for both growth and ability to fold CPY in vivo, a li-
brary of CxxC mutants (x denotes a random amino acid
residue) was constructed. The mutagenesis was carried out
on a plasmid encoding the SGHS-SGHS mutant. Two in-
dependent libraries of mutants were made so that each li-
brary converted only one of the two active sites from
SGHS to CxxC. Each pool of mutant plasmids was intro-
duced into a Dpdi1 yeast strain and tested for complemen-
tation. Survival required the introduction of both the nec-
essary cysteine residues as well as the mutagenesis of the
intervening GH sequence. From the mutant pools, a col-
lection of 10 and 12 clones, respectively, were isolated and
sequenced (Table II). We have not analyzed the identity
or frequency of noncomplementing mutants. All comple-
menting mutants, along with wild-type PDI, the CGHC-
SGHS, and the SGHS-CGHC mutants, were further char-
acterized by sensitivity to DTT. This test was chosen since
DTT is known to penetrate into the ER and interfere with
the formation of disulfide bonds in nascent disulfide-con-
taining proteins. We adjusted the pH in the plates to 5 and
incubated them in a CO2 atmosphere to reduce the spon-
taneous oxidation of the DTT. The wild-type and the
CGHC-SGHS mutant grow on 5 mM DTT. The SGHS-
CGHC mutant, which showed increased sensitivity to
DTT in the pulse-labeling experiment, also shows a weaker
growth on plates containing DTT (Fig. 3). In Table II, the
mutants are sorted according their DTT sensitivity. Since
the DTT sensitivity is, in most cases, not an all-or-nothing
relationship, many of the mutants are classified as having
the same sensitivity threshold. Nevertheless, using media
containing a spectrum of DTT concentrations, a clear or-
der of the ranking of growth rates was observed within
each class. No significant growth phenotype was found un-
der aerobic or anaerobic conditions in the absence of DTT
(Fig. 3). In the CxxC mutants of DsbA, an increased DTT
sensitivity of the bacteria correlates with a more reducing
redox potential (Grauschopf et al., 1995). By analogy, it is
likely that a similar ranking of the yeast PDI mutants re-
flects a ranking of redox potential.
All mutants were analyzed further by pulse-chase label-
ing and immunoprecipitation of CPY, as described above,
and a correlation was found between rate of ER exit and
Figure 2. Inactivation of the PDI a domain results in reduced
rate of CPY maturation and inability to recover from DTT treat-
ment. (A) Cells were pulse-labeled with 35S-labeled amino acids
for 15 min and chased with nonradioactive sulfur for the indi-
cated periods of time. Intracellular CPY was immunoprecipi-
tated, separated by 8% SDS-PAGE, and exposed to Phosphor-
Imager screens. Mutants are identified according to the sequence
of their CXXC motifs. (B) Cells were pulse labeled for 20 min as
described above, but in the presence of 5 mM DTT. They were
then washed with unlabeled DTT-free medium and chased in this
medium for the indicated periods of time. The SGHS-CGHC mu-
tant is not able to oxidize and mature p1-proCPY (lane 9), while
the wild type (lanes 1–3) and the CGHC-SGHS mutant (lanes 4–6)
show similar maturation rates. In accordance with earlier
observations (Simons et al., 1995; Holst et al., 1996), the rate of
maturation is considerably slower after treatment with DTT. A
partial degradation of the CPY antigen, like the one seen in this
experiment, is often found under folding defective conditions
(Ramos and Winther, 1996).Holst et al. Yeast Protein Disulfide Isomerase Function 1233
in vivo sensitivity towards DTT. Labeled immunoprecipi-
tates of CPY from representative mutants are shown in
Fig. 4. The labeling shows that the rate of transport is re-
duced considerably for the mutants, as compared to the
wild type. The CGSC-SGHS mutant, which is sensitive to
1 mM DTT (Table II), has a half time of maturation only
slightly longer than the wild type (8–10 min). The CSGC-
SGHS mutant has a half-time of maturation of z15 min
and a DTT sensitivity threshold of 0.2 mM. In the most
DTT-sensitive mutant (CRRC-SGHS), proCPY is ma-
tured with a half time of z30 min, as compared to 6 min
for cells containing wild-type PDI.
Oxidation-deficient Mutants
The ability of enzymes in the thioredoxin family to cycle
efficiently between an oxidized and reduced state depends
on the presence of an intramolecular disulfide bond in the
CXXC motif (Fig. 1 B). However, only the more NH2-
proximal of the two cysteine residues plays an essential
role in the isomerization reaction. This is because only this
residue engages in the formation of mixed disulfides with
the substrate polypeptide (Fig. 1 C; Wunderlich et al.,
1995; Walker et al., 1996).
After considering the effect of random changes to the
redox potential of PDI, we wished to analyze the most oxi-
dation-deficient mutants that we could conceivably con-
struct without the loss of isomerase activity. Efficient oxi-
dation is possible only when both active-site cysteines are
present (Fig. 1, B and C). Thus, mutants of the CGHS-
type should not be able to perform the internal redox
chemistry, but should still be able to function as isomerases.
Figure 3. Sensitivity of CxxC mutants to DTT in the growth me-
dium. Diluted suspensions of cells expressing selected PDI1 mu-
tants were plated on media without DTT or with 2 mM DTT.
Plates were incubated in a CO2 atmosphere at 308C and photo-
graphed after 2 and 4 d. Mutants are identified by their active-site
sequences.
Table II. DTT Sensitivity of PDI CxxC Mutants
Enzyme
(a domain mutants)
DTT sensitivity
threshold
Enzyme
(a9 domain mutants)
DTT sensitivity
threshold
mM mM
CGHC-CGHC 5 CGHC-CGHC 5
CGHC-SGHS 5 SGHS-CGHC 3
CLYC-SGHS 2 SGHS-CCPC 3
CKIC-SGHS 1 SGHS-CPKC 3
CGSC-SGHS 1 SGHS-CRNC 3
CGCC-SGHS 0.5 SGHS-CVDC 3
CGGC-SGHS 0.5 SGHS-CHQC 2
CRPC-SGHS 0.2 SGHS-CGTC 1
CSGC-SGHS 0.2 SGHS-CKAC 1
CWSC-SGHS 0.2 SGHS-CGEC 0.5
CWLC-SGHS 0.2 SGHS-CNCC 0.5
CRRC-SGHS 0.2 SGHS-CRSC 0.5
SGHS-CSGC 0.5
SGHS-CPSC 0.5
Mutants were plated on selective media containing various concentrations of DTT, as
described in Fig. 3, and were monitored for growth after 3 d. The sensitivity does not
have an absolute threshold, but it gives a clear ranking (less than two positions) of the
mutants as indicated above, even within the same sensitivity class.The Journal of Cell Biology, Volume 138 1997 1234
It has been shown previously that the CGHA mutant
forms of PDI will complement a pdi1 deletion (LaMantia
and Lennarz, 1993). Similarly, overexpressed EUG1, a
PDI homologue with a CXXS motif in both thioredoxin
domains, can support growth of a Dpdi1 strain (Tachibana
and Stevens, 1992). We constructed the CGHS-CGHS,
CGHS-SGHS, and SGHS-CGHS mutants and found, in
accordance with previous results, that they did support
growth. However, the three CGHS mutants all show re-
duced rates of growth. Furthermore, they are extremely
sensitive to DTT on plates. While the slowest growth rate
is seen for the CGHS-SGHS mutant (Fig. 5 A), pulse-
chase experiments showed that the CPY folding was most
severely affected in the SGHS-CGHS mutant (Fig. 5 B).
This shows that there is no direct correlation between rate
of growth and rate of intracellular CPY folding. This con-
clusion is supported further by the observation that the
rate of CPY maturation in the CRRC-SGHS mutant is as
slow as that of the CGHS-SGHS mutant, while the growth
rate of the former is essentially the same as wild type. This
also suggests the existence of specific PDI substrates that
are essential for optimal cell growth and more dependent
than CPY on PDI catalysis.
Reconstruction of a Thioredoxin-like Active Site
in Eug1p
The EUG1 gene was originally isolated by its homology to
PDI1 (Tachibana and Stevens, 1992). The Eug1p protein
is uniquely different from PDI since it has CLHS-CIHS in
place of the of CGHC-CGHC active site sequences. The
expression of EUG1 under normal growth conditions is
z5–10% of that of PDI1 (Tachibana and Stevens, 1992).
We found that EUG1 complemented the growth defect of
a pdi1 deletion when expressed under control of the PDI1
promoter (Fig. 6). It did so, however, only to an extent
similar to that of the CGHS-CGHS mutant of PDI, i.e.,
the growth rate was considerably reduced compared to
wild type. This suggested that the main reason that EUG1
does not fully complement Dpdi1 is the absence of the
COOH-proximal active-site cysteines. To investigate this
hypothesis, we attempted to convert Eug1p to a more
PDI-like enzyme by changing the CLHS-CIHS sequences
to genuine thioredoxin-type active sites CLHC-CIHC. In-
deed, under control of the PDI1 promoter, this EUG1 mu-
tant allowed a Dpdi1 strain to grow at an essentially wild-
type rate (Fig. 6). The obvious interpretation of this result
is that the mutant Eug1p gained the ability to form inter-
nal cystine bridges in the two active sites, allowing oxida-
tive activity as well as disulfide isomerase activity.
Assaying Folding In Vivo Using Glycosyl Modification 
of Buried Sites
To test the rate of folding in the PDI mutants more di-
rectly, we used a mutant form of CPY in which a new site
for asparagine-linked glycosylation has been introduced at
a buried position in the protein structure. The mutant pro-
tein, CPY-3T (Holst et al., 1996), is useful because the
level of glycosylation at the new site is dependent on the
folding rate of the protein. Thus, no glycosylation of this
Figure 4. DTT-sensitive PDI
mutants have a reduced rate
of CPY maturation. Pulse la-
beling and immunoprecipita-
tion was carried out as de-
scribed in Fig. 2 A. Mutants
are identified by their active-
site CXXC motifs; the left
panel represents the wild-
type  a domain.
Figure 5. PDI CGHS mutants show reduced rates of growth and
CPY maturation. (A) Cells producing CGHS active-site mutant
forms of PDI were streaked on YPD and photographed after 3 d.
(B) The same mutants were subjected to pulse labeling and im-
munoprecipitation of CPY, as described in Fig. 2 A.Holst et al. Yeast Protein Disulfide Isomerase Function 1235
site takes place under normal growth conditions, while in
the presence of DTT the mutant shows z40% modifica-
tion of the buried acceptor site. Overglycosylation results
in a shift in SDS-PAGE mobility approximately equal to
the p2 modification, making precise evaluation of the level
of overglycosylation difficult when the protein is not sub-
stantially retained in the ER. We have therefore expressed
the mutants in a sec18 strain that is blocked in the ER exit
at the nonpermissive temperature (Stevens et al., 1982).
The only band immunoprecipitated from the PDI1 wild-
type control strain corresponds to p1-proCPY (Fig. 7, lane
2), indicating that no modification is taking place at the
buried site. The strains expressing various mutant PDIs
show varying degrees of overglycosylation of CPY-3T.
The level of overglycosylation is highest in the pdi1 mu-
tants with the slowest rate of ER exit found for wild-type
CPY. This confirms that the rate of CPY folding is re-
duced in these mutants.
Discussion
In this work, we have addressed some basic questions con-
cerning the function of PDI in vivo. There is ample bio-
chemical evidence that PDI activity is exerted through the
action of two thioredoxin-like domains, a and a9, which
have a very high level of mutual similarity. Using rat PDI
expressed in yeast, Laboissiere et al. (1995) showed that
the simultaneous mutation of the CGHC active-site se-
quences of these domains to SGHS generates an enzyme
that is unable to support yeast growth. Our mutagenesis of
yeast PDI does not support an earlier proposal that yeast
PDI possesses an essential “chaperone” function (LaMan-
tia and Lennarz, 1993). The combined evidence indicate
that the ability of PDI to engage in disulfide chemistry is
essential for the viability of yeast.
Considering the mutual sequence similarity and the in
vitro evidence that both thioredoxin domains are able to
engage in disulfide chemistry, we wished to investigate the
relative importance of the two domains for folding of
CPY. CPY is an exceedingly well-characterized model
substrate in terms of biosynthesis and folding both in vivo
and in vitro (Stevens et al., 1982; Winther et al., 1991; Ra-
mos et al., 1994; Holst et al., 1996), and requires the pres-
ence of at least some of its five disulfide bonds for folding
(Jämsä et al., 1994). We have used two methods for moni-
toring the folding rate in vivo. One relies on the presence
of a quality control system in the ER (Ramos et al., 1994;
Gething et al., 1986). This mechanism ensures that only
correctly folded proteins are allowed to exit the ER and
proceed through the secretory pathway. Our other assay
for in vivo folding takes advantage of a mutant form of
CPY that contains an N-linked glycosylation site at a bur-
ied position in the protein structure. This site becomes
partially glycosylated if folding is compromised (Holst et
al., 1996). In both assays for folding, we find that a mutant
enzyme that contains only an active a site (the CGHC-
SGHS mutant) is as efficient in folding CPY as the wild-
type enzyme. The SGHS-CGHC mutant, on the other
hand, shows a significantly slower CPY folding. This is the
first in vivo evidence that the two thioredoxin domains are
functionally different. This might reflect differences in
substrate specificity between the domains, but as we shall
see below, could also be explained by differences in redox
potential.
The intramolecular disulfide bond between the two cys-
teine residues of thioredoxin-like proteins can be charac-
terized with respect to its redox potential. Thioredoxins
Figure 6. Mutants of Eug1p converting CXXS active site motifs
to CXXC show improved growth. Shown are: yeast cells deleted
for the chromosomal copies of PDI1 and EUG1 containing plas-
mids with PDI1 ( PDI), wild-type EUG1 under control of the
PDI1 promoter (Eug1p) or a mutant form of EUG1 containing a
CIHC-CLHC active site sequences (Eug1p-CXXC). EUG1 ex-
pressed from the PDI1 promoter is able to complement a pdi1
deletion, albeit with a considerably reduced growth rate. The
growth deficiency of this strain is essentially corrected by the in-
troduction of CXXC active site motifs.
Figure 7. PDI1 mutants show glycosylation of a buried sequence
for N-linked glycosylation in CPY-3T. Cells were 35S-labeled for
30 min without chase. Labeling was carried out at 378C, which is
restrictive for the temperature-sensitive sec18-1 mutation. This
blocks ER exit and ensures that no p2proCPY is formed. The
band marked p1* thus arises from glycosylation of the buried site.
In cells expressing wild-type PDI1 or the CGHC-SGHS mutant,
no p1* form is observed, while an increasing fraction of the newly
synthesized CPY-3T is modified in lanes 4–7. Lane 1 shows wild-
type CPY in the same strain at the permissive temperature.The Journal of Cell Biology, Volume 138 1997 1236
from various sources have fairly reducing redox potentials,
while PDIs are generally characterized by a very oxidizing
active-site cystine bond (Bardwell and Beckwith, 1993).
This is true in spite of the observation that the three-
dimensional structures of the various thioredoxin-like
domains are virtually superimposable (Martin, 1995; Kem-
mink et al., 1996). In DsbA, an enzyme from E. coli with a
function similar to that of PDI, the relevance of the two
central residues in the CGHC motif has been investigated
extensively (Grauschopf et al., 1995). Changing these resi-
dues had marked effects on the redox potential of the en-
zyme. DsbA mutants showed increased sensitivity to DTT
for folding of a chimeric malF-b-galactosidase fusion pro-
tein in vivo. Importantly, the sensitivity was inversely re-
lated to the oxidative power, which was determined on the
purified mutant enzymes in vitro. Thus, it appears that the
wild-type E. coli version of PDI is able to overcome the re-
ducing power of DTT in an in vivo folding reaction. In
yeast and higher eukaryotes, DTT is able to penetrate into
the cells and inhibit the folding of disulfide bonded pro-
teins (Braakman et al., 1991). In particular, this has been
shown for CPY in yeast (Jämsä et al., 1995; Simons et al.,
1995). We find that wild-type cells are seriously inhibited
for growth on plates containing 10 mM DTT at pH 5 under
anaerobic conditions; however, cells will grow at 5 mM
DTT. The ability of cells to grow on DTT-containing me-
dium is strongly dependent on PDI function. We have
shown that the CGHC-SGHS and SGHS-CGHC mutants
have different growth rates on DTT plates. While the
CGHC-SGHS mutant grew as well as the wild type on 5
mM DTT, the SGHS-CGHC mutant showed increased
sensitivity and grew like the wild type only on plates con-
taining 3 mM DTT or less. This is in accordance with the
observation on human PDI that the a domain is more oxi-
dizing than the a9 domain (Darby and Creighton, 1995b).
It is also interesting to compare these data with results
from Walker et al. (1996), following the oxidative refold-
ing of RNase using similar mutants of human PDI in vitro.
In these experiments, the oxidative folding of RNase was
faster in the presence of a PDI with a mutated a9 site than
in the presence of a PDI with a mutated a site. Taken to-
gether, these results indicate that the initial oxidative for-
mation of disulfide bonds may be a rather important as-
pect of PDI function. The difference in the rate of CPY
folding by PDI mutants disrupted in the a and a9 domains
might reflect differences in their ability to oxidize sub-
strate. Mutagenesis of the cysteines engaged in disulfide
bonds in CPY has shown that several of these are impor-
tant for folding in vivo (Jakobsen, A., and J.R. Winther,
unpublished observations). However, the actual rates of
ER exit probably cannot be directly correlated to in vitro
observations since characterization of CPY propeptide
mutants has shown that rates of folding in vivo and in vitro
can only be related qualitatively (Lunde, C., and J.R. Win-
ther, unpublished observations).
To investigate the importance of the redox potential of
PDI, we randomly mutagenized the two central amino
acid residues in the CGHC motif in both the a and a9
domains. The mutants were initially selected for comple-
mentation of a chromosomal pdi1 deletion. Sequencing a
number of randomly chosen mutants showed a clear over-
representation of the helix-breaking residues Gly and Pro
(Table II). This bias is not unreasonable considering the
presence of the CGHC sequence at the beginning of helix
2 of the thioredoxin fold (Fig. 1 A). Apart from this trend,
we do not find any obvious characteristics or similarities
among these sequences. The mutants showed little or no
growth phenotype under normally oxidizing conditions.
The screening procedure, however, would probably im-
plicitly select against mutant forms giving very slow growth
phenotypes. Many of the mutants proved to be extremely
DTT sensitive (Table II). A priori, it might not be obvious
that DTT should inhibit growth of the cells because of its
effect on disulfide bond formation. There could, in princi-
ple, be several reasons for the toxic effects of DTT. These
results, however, indicate a direct link between PDI struc-
ture/function and growth rate on various concentrations of
DTT, and they imply that toxicity is evoked specifically
through inhibition of the folding of disulfide-bonded
secretory proteins. In accordance with this hypothesis, in-
vertase, a secretory protein without disulfide bonds, is se-
creted normally in the presence of DTT at concentrations
that completely blocked proCPY ER exit (data not shown;
Jämsä et al., 1994). This suggests that the secretory path-
way as such is not perturbed by DTT treatment, but that
the effect is specific to proteins containing disulfide bonds.
By analogy to DsbA, we propose that our DTT-sensitive
PDI mutants are altered in their redox potential (Fig. 4).
The mutants are affected in their rate of CPY folding in
the ER, as demonstrated by the reduced rate of exit from
the ER of CPY in the PDI mutant backgrounds. The re-
duced folding rate is also seen in a more direct way by the
observation that CPY-3T (Holst et al., 1996) is glycosy-
lated at a buried N-glycosylation site in the PDI mutants
but not in the wild type. Thus, the overglycosylation of the
CPY-3T mutant would strongly suggest that the PDI mu-
tants are affected in early folding events associated with
the introduction of disulfide bonds. The importance of the
redox potential for “PDI function” has also been high-
lighted in studies by Chivers et al. (1996). Here, a signal
peptide was introduced in front of E. coli thioredoxin to
target it to the ER. In such a construct, thioredoxin is not
able to complement a PDI deletion. However, CxxC mu-
tants were selected by their ability to complement a pdi1
deletion, and it was found that only mutants with a more
oxidizing redox potential could complement the yeast
PDI1 deletion. This supports the notion that oxidation is
an important, albeit not essential, function of PDI in terms
of supporting yeast growth.
To examine extreme effects on deficiency in oxidative
power, we constructed CGHS mutants that are unable to
form the normal active site disulfide bonds. It is likely that
such mutations would not abolish all PDI activity, since
they are not lethal for yeast and CHGS mutants are still
able to catalyze oxidation reactions by formation of a
mixed disulfide with glutathione (Wunderlich et al., 1995;
Walker et al., 1996). CPY folding in cells expressing the
CGHS-SGHS and SGHS-CGHS mutants was not signifi-
cantly slower than in the most DTT-sensitive CxxC mu-
tant (e.g., CRRC-SGHS). Nascent proCPY might be oxi-
dized even in the absence of the oxidative power of PDI
by the endogenous GSH-GSSG redox buffer in the ER
(Hwang at al., 1992) or by another other PDI homologue.
MPD1, for example, is able to suppress the lethality of aHolst et al. Yeast Protein Disulfide Isomerase Function 1237
pdi1 deletion when expressed from a high copy plasmid
(Tachikawa et al., 1995) or under the control of the PDI1
promoter (Holst, B., and J.R. Winther, unpublished obser-
vations). Although this enzyme is not normally produced
at levels that would sustain growth in the absence of PDI,
it may provide a background of oxidizing power seen in
the CGHS mutants.
Despite the similarity between the most extreme CxxC
mutants and the CGHS mutants in the rate of CPY fold-
ing, there is a marked difference in the way they affect the
growth rate. This suggests that other substrates, which are
required for optimal growth rates, have a stronger require-
ment for the oxidative power of PDI. It is somewhat sur-
prising that the CGHS-SGHS mutant grows more slowly
than the SGHS-CGHS mutant, since it seems to contradict
the conclusion that the a site is more important for CPY
folding than the a9 site. However this may be because the
a9 domain is more important for the growth-essential sub-
strate(s) than the a domain.
The yeast PDI-like protein Eug1p does not contain the
second cysteine residue of the CXXC motif, yet it is able
to sustain viability when overexpressed. EUG1, under the
control of the PDI1 promoter, complements a pdi1 dele-
tion, and the growth rate of such cells is comparable to
that of a CGHS-CGHS PDI mutant. In view of the current
interest in the relevance of PDI activity for yeast survival,
we investigated the effect of mutating the CLHS-CIHS ac-
tive-site sequences of Eug1p “back” to thioredoxin-like
structures: CLHC-CIHC. Presumably, wild-type Eug1p
can isomerize disulfide bonds, but it can oxidize only by
first forming a mixed disulfide with GSH. The altered
Eug1p should be able to form an internal active-site disul-
fide bond, which would greatly facilitate its ability to act as
an oxidant. The observation that these mutants, when ex-
pressed from the PDI1 promoter, complemented the pdi1
deletion to an almost wild-type growth rate indicates that
genuine PDI activity can be achieved by the altered Eug1p. It
also underscores the importance of the oxidative function
of PDI. The implication that Eug1p is able to adapt a
thioredoxin-type mechanism is interesting from both an
enzymatic and an evolutionary point of view. Sequencing
of the yeast genome has revealed an ancient duplication
that is reflected the presence of two homologous copies of
most genes. It is likely that EUG1 and PDI1 constitute such a
pair since they belong to the same duplication “block”
(http://acer.gen.tcd.ie/zkhwolfe/yeast/topmenu.html). Also,
the apparent absence of Eug1p homologues of nonyeast
origin suggests that Eug1p has evolved from PDI fairly re-
cently. This may also explain why the enzyme mechanism
can be changed by a single amino acid substitution. The
fact that CPY folding occurs as slowly in the Eug1p mu-
tant (not shown) as in a CRRC-SGHS PDI mutant is not
surprising since it is probably not very oxidizing. In vitro
characterization is in progress to compare biochemical
properties of both wild-type and mutant forms of PDI and
Eug1p.
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